MLN4924 was found to trigger epidermal growth factor receptor (EGFR) dimerization and activate EGFR downstream signaling pathways such as RAS/RAF/MEK/ERK and PI3K/AKT1/mTOR promoting tumor sphere formation and inducing wound healing in mouse models. Here, MAP2K7 is linked to neoplasm.